Torigen Pharmaceuticals, Inc. produces an experimental Autologous Prescription Product regulated by the USDA Center for Veterinary Biologics. For use under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.

Torigen Pharmaceuticals, Inc. produces an experimental Autologous Prescription Product regulated by the USDA Center for Veterinary Biologics. For use under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.

Torigen Pharmaceuticals, Inc. produces an experimental Autologous Prescription Product regulated by the USDA Center for Veterinary Biologics. For use under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.

Torigen in the News

Torigen in the News

Torigen in the News

Torigen in the News

Torigen in the News

Torigen in the News

News Releases

Torigen Pharmaceuticals Opens New Headquarters and Promotes Two to Executive Leadership

April 25, 2023

Torigen Pharmaceuticals and Veterinary Management Groups Enter into Preferred Partner Agreement

April 13, 2023

CT Tech Council Member Spotlight: Torigen Pharmaceuticals

February 4, 2023

Torigen Pharmaceuticals and VerticalVet Enter into Preferred Partnership

December 8, 2022

Three Notre Dame alumni who are changing the world - powered by ESTEEM

December 4, 2022

Torigen Pharmaceuticals Announces Completion of $13M Capital Raise

November 17, 2022

2022 Power 25 Health Care: Ashley Kalinauskas

October 25, 2022

Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health

July 5, 2022

Cancer Immunotherapies as Treatment For Your Pets

April 17, 2022

Torigen Expands Histopathology Services Through Strategis Partnership with Vidium Animal Health

April 17, 2022

Pet Cancer Vaccine Maker Torigen Pharmaceuticals Expanding with New Lease, Venture Funding

February 2, 2022

Torigen Appoints Veterinary Oncologist, Dr. Chelsea Greenberg, as Vice President of Clinical Affairs

October 15, 2021

Field safety experience with an autologous cancer vaccine in tumor-bearing cats: a retrospective study of 117 cases (2015–2020)

August 6, 2021

Torigen Wins Big at Yale Innovation Summit and Animal Health Innovation Showcase

July 9, 2021

Following $3.5M fundraise, Farmington's Torigen Pharmaceuticals signs distribution deal with Victor Medical Group

June 11, 2021

Torigen Pharmaceuticals Signs First Distribution Agreement with Victor Medical Company

June 9, 2021

Finding Solutions in Veterinary Healthcare to Improve Animal Health

April 27, 2021

When a Vet Oncology Referral Isn't in the Cards for a Patient

January 20, 2021

Torigen Announces Positive Results for Dogs Administered the Company’s Autologous Cancer Vaccine

December 3, 2020

Modulating the Immune System to Fight Animal Cancer in Pets

July 30, 2020

Interviews and Podcast Features

Podcast Feature: Tenacity with Sonia C.

July 23, 2024

Podcast Feature: Women's Biz Podcast

July 3, 2024

Podcast Feature: Vetsplanation

June 18, 2024

Podcast Feature: Progress, Potential, and Possibilities

April 17, 2024

Podcast Feature: Her Balanced Hustle

February 27, 2024

Podcast Feature: Pretty Powerful Podcast

January 16, 2024

Interview: Canine Cancer Alliance

October 10, 2023

Podcast Feature: The Veterinary Optimist

September 1, 2023

Podcast Feature: Torigen Talks Immunotherapy Vaccine with Tripawd

May 27, 2021

Podcast Feature: The Vet Blast Podcast

February 4, 2021

Blog Articles
Coming Soon!

6 Executive Dr., Suite 118

Farmington, CT 06032

P: 860.519.9956

6 Executive Dr., Suite 118

Farmington, CT 06032

P: 860.519.9956

©2024 Torigen Pharmaceuticals Inc. | All rights reserved

©2024 Torigen Pharmaceuticals Inc. | All rights reserved